International Association for the Study of Lung Cancer

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

Fred R. Hirsch, Abigail McElhinny, Dave Stanforth et al. · Journal of Thoracic Oncology · 2016 · 1.2K citations · Full text

Cancer Immunosurveillance, Advanced Lung Disease, Medicine +8

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Archives of Pathology & Laboratory Medicine · 2018 · 887 citations · Full text

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Ming‐Sound Tsao, Keith M. Kerr, Mark Kockx et al. · Journal of Thoracic Oncology · 2018 · 793 citations · Full text

Real-life Clinical Samples, Biomarker (Medicine), Translational Medicine +12

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Journal of Thoracic Oncology · 2018 · 615 citations · Full text

Oncology, Medicine, Bronchial Neoplasm +8

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

André L. Moreira, Paolo Ocampo, Yuhe Xia et al. · Journal of Thoracic Oncology · 2020 · 511 citations · Full text

Cancer Detection, Grading System, International Association +11